Max Robotics — Global Service Robot Directory + US Certification

About

Hirohisa Miura is a surgical researcher whose work centers on minimally invasive approaches to rectal cancer treatment, with a particular focus on comparing robotic-assisted laparoscopic surgery (RALS) against conventional laparoscopic surgery (CLS). His research addresses one of the most actively debated questions in colorectal surgery: whether robotic platforms offer meaningful clinical advantages over established laparoscopic techniques. Miura's most impactful contributions include a series of rigorous propensity score-matched analyses that evaluate both short- and long-term surgical outcomes in rectal cancer patients, including the challenging subgroup undergoing neoadjuvant chemoradiotherapy prior to surgery. His 2022 study comparing RALS and CLS across 303 consecutive patients has accumulated 20 citations, making it his most-referenced work, while his investigation of outcomes following neoadjuvant chemoradiotherapy has garnered 12 citations. A retrospective cohort study examining long-term outcomes adds further depth to his portfolio with 9 citations. Collectively, Miura's body of work provides surgeons and oncologists with evidence-based insights into the safety, feasibility, and technical trade-offs of robotic rectal surgery, helping to guide clinical decision-making in an era of rapidly evolving surgical technology.